Analysts at SunTrust Robinson Humphrey initiated coverage on Regeneron Pharmaceuticals Inc REGN with a Neutral rating. The target price for Regeneron Pharmaceuticals is set to $450. Regeneron Pharmaceuticals shares closed at $407.81 on Wednesday.
KeyBanc initiated coverage on Saia Inc SAIA with a Sector Weight rating. Saia shares closed at $26.66 on Wednesday.
Analysts at Numis Securities initiated coverage on GW Pharmaceuticals PLC- ADR GWPH with a Sell rating. GW Pharmaceuticals shares closed at $40.97 on Wednesday.
Analysts at B. Riley initiated coverage of Intralinks Holdings Inc IL with a Buy rating. The target price for Intralinks Holdings is set to $14.25. Intralinks Holdings shares closed at $7.79 on Wednesday.
Analysts at Berenberg initiated coverage on Alcoa Inc AA with a Hold rating. The target price for eBay is set to $9. Alcoa shares closed at $9.63 on Wednesday.
Analysts at Citigroup initiated coverage on Ardelyx Inc ARDX with a Buy rating. The target price for Ardelyx is set to $15. Ardelyx shares closed at $10.54 on Wednesday.
Analysts at H.C. Wainwright initiated coverage on Ligand Pharmaceuticals Inc. LGND with a Buy rating. The target price for Ligand Pharmaceuticals is set to $146. Ligand Pharmaceuticals shares closed at $97.54 on Wednesday.
Raymond James initiated coverage on RPC, Inc. RES with a Strong Buy rating. The target price for RPC is set to $17. RPC shares closed at $14.16 on Wednesday.
Guggenheim Securities initiated coverage on Seres Therapeutics Inc MCRB with a Buy rating. The target price for Seres Therapeutics is set to $41. Seres Therapeutics shares closed at $26.73 on Wednesday.
SunTrust Robinson Humphrey initiated coverage of Seattle Genetics, Inc. SGEN with a Neutral rating. The target price for Seattle Genetics is set to $34. Seattle Genetics shares closed at $32.46 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in